phenethyl isothiocyanate has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Q; Liu, C; Xiao, Z; Zhan, X | 1 |
| Chou, ST; Chung, JG; Hsia, TC; Huang, AC; Ko, YC; Liao, CL; Lu, HF; Ma, CY; Wu, CL; Yang, JS | 1 |
2 other study(ies) available for phenethyl isothiocyanate and Bone Cancer
| Article | Year |
|---|---|
Phenethyl isothiocyanate enhances adriamycin‑induced apoptosis in osteosarcoma cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Humans; Isothiocyanates; Osteosarcoma; Signal Transduction | 2015 |
Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic
Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; DNA Damage; Drug Evaluation, Preclinical; Enzyme Activation; Humans; Isothiocyanates; Membrane Potential, Mitochondrial; Nitric Oxide; Osteosarcoma; Reactive Oxygen Species; Signal Transduction | 2011 |